Opsens Revenue and Competitors

Quebec City, QC CAN

Location

$64.7M

Total Funding

Estimated Revenue & Valuation

  • Opsens's estimated annual revenue is currently $66.5M per year.(i)
  • Opsens received $8.0M in venture funding in March 2019.
  • Opsens's estimated revenue per employee is $313,750
  • Opsens's total funding is $64.7M.

Employee Data

  • Opsens has 212 Employees.(i)
  • Opsens grew their employee count by 0% last year.

Opsens's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
Senior R&D Director - New Products DevelopmentReveal Email/Phone
3
Director Sales and Clinical Development EMEA & JapanReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director, New Business DevelopmentReveal Email/Phone
7
Manager, Human Resources-Commercial OperationsReveal Email/Phone
8
Gestionnaire de projet / Project ManagerReveal Email/Phone
9
Territory ManagerReveal Email/Phone
10
Customer Service Manager and Data EntryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M21-32%$26.7MN/A
#2
$45.4M18112%N/AN/A
#3
$0.5M4-80%$4MN/A
#4
$90.9M3629%N/AN/A
#5
$11.3M4545%N/AN/A
#6
$12.6M504%N/AN/A
#7
$46.9M187-18%N/AN/A
#8
$6.5M268%N/AN/A
#9
$66.5M2120%$64.7MN/A
#10
$33.1M1328%N/AN/A
Add Company

What Is Opsens?

Opsens focuses on the measure of FFR in interventional cardiology, offering an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. Opsens is also involved in industrial activities. The Company develops, manufactures and installs fibre optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications. Opsens aims to become a key player in the FFR market with the OptoWire, a nitinol-based optical guidewire. The OptoWire provides intra-coronary blood pressure measurements with unique, patented technologies. Immune to the adverse effects related to blood contact, it allows easy and reliable connectivity that leads to reliable FFR measurements in extended conditions of usage. It is also designed to provide cardiologists with optimized performances to navigate coronary arteries and cross blockages with ease and safety. Based on industry sources, the FFR market represented more than US$300 M in sales in 2014. It is expected to reach US$1 B med-term. Opsens Solutions, a leading manufacturer of fiber optic sensors, presents its latest advances with its White-Light Polarization Interferometry (WLPI) technology and its SemiConductor Band Gap (SCBG) technology. With several new sensor models, Opsens Solutions provides high-accuracy, high-stability measurements, and high-resolution detection solutions to meet the needs of industries such as: Downhole fiber optic pressure and temperature sensor for Oil and Gas Temperature & pressure monitoring for Energy-related applications Precise instrumentation for Defense and Aerospace Customized OEM fiber optic sensor solutions Our technology can measure temperature, pressure, linear displacement, constraint, force and load. Our sensors perform in many harsh environments and at high temperatures. They are also insensitive to RF radiation, MRI, EMI, nuclear and microwave.

keywords:Agriculture,Cleantech,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Pharmaceuticals,Solar Power,Wind Power

$64.7M

Total Funding

212

Number of Employees

$66.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Opsens News

2022-04-19 - Insider Selling: Opsens Inc. (CVE:OPS) Senior Officer Sells ...

Get Opsens alerts: On Thursday, January 27th, Robin Villeneuve sold 50,000 shares of Opsens stock. The stock was sold at...

2022-04-13 - OPSENS ANNOUNCES SECOND QUARTER FISCAL 2022 ...

QUEBEC, April 13, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused...

2022-04-13 - Opsens Inc.'s (OPSSF) CEO Louis Laflamme on Q2 2022 Results - Earnings Call Transcript

Good morning, everyone, and thank you all for joining us today for the OpSens second quarter fiscal year 2022 conference call for the period...

2021-11-23 - OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results

Conference call on the results today at 11 a.m. ET QUEBEC CITY, Nov. 23, 2021 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today reported ...

2021-07-13 - OpSens : Announces Third Quarter Fiscal 2021 Record Financial Results

Conference call on the results to be held today at 11 a.m. QUEBEC CITY, July 13, 2021 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical tech ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M228-68%N/A
#2
$37M2328%N/A
#3
$99.2M3726%$46.2M
#4
$62.5M4900%N/A
#5
$129.9M4958%N/A

Opsens Funding

DateAmountRoundLead InvestorsReference
2019-03-01$8.0MUndisclosedCIBC Innovation BankingArticle